Tel: 0755-85269922 E-mail: sales@biochemmall.com
ICP:粤ICP备19135875号
GZD824 Dimesylate is a novel oral effective Bcr-Abl inhibitor that acts on Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
Brand: BCM
Solubility: Soluble in DMSO; soluble in Water. Insoluble in Ethanol.
Attribute [Chem Name] GZD824 Dimesylate [CAS No.] 1421783-64-3 [Formula] C31H35F3N6O7S2 [Molecular] 724.771 [Synonym] HQP1351; Olverembatinib dimesylate [MDL No.] MFCD26142656 [Form] Solid
Goods Tag